Detalles de la búsqueda
1.
An optimized protocol for the generation and monitoring of conditional orthotopic lung cancer in the KP mouse model using an adeno-associated virus vector compatible with biosafety level 1.
Cancer Immunol Immunother
; 72(12): 4457-4470, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37796299
2.
Targeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtDNA damage.
Cell Mol Life Sci
; 79(8): 445, 2022 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35877003
3.
Clinical and Oncological Outcomes after Uniportal Anatomical Segmentectomy for Stage IA Non-Small Cell Lung Cancer.
Medicina (Kaunas)
; 59(6)2023 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37374269
4.
Schedule-Dependent Treatment Increases Chemotherapy Efficacy in Malignant Pleural Mesothelioma.
Int J Mol Sci
; 23(19)2022 Oct 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36233258
5.
EpCAM+CD73+ mark epithelial progenitor cells in postnatal human lung and are associated with pathogenesis of pulmonary disease including lung adenocarcinoma.
Am J Physiol Lung Cell Mol Physiol
; 319(5): L794-L809, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32726135
6.
CD90+CD146+ identifies a pulmonary mesenchymal cell subtype with both immune modulatory and perivascular-like function in postnatal human lung.
Am J Physiol Lung Cell Mol Physiol
; 318(4): L813-L830, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32073879
7.
Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment.
Cancer Cell Int
; 19: 317, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31798346
8.
ERS/EACTS statement on the management of malignant pleural effusions.
Eur Respir J
; 52(1)2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30054348
9.
Xiphoidectomy for Intractable Xiphodynia.
World J Surg
; 42(11): 3646-3650, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29770873
10.
Schedule-dependent increased efficiency of pemetrexed-ionizing radiation combination therapy elicits a differential DNA damage response in lung cancer cells.
Cancer Cell Int
; 16(1): 66, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27594806
11.
Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT.
BMC Cancer
; 16: 125, 2016 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26895954
12.
Pneumothorax risk reduction during CT-guided lung biopsy - Effect of fluid application to the pleura before lung puncture and the gravitational effect of pleural pressure.
Eur J Radiol
; 176: 111529, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38810440
13.
BAP1 Deficiency Inflames the Tumor Immune Microenvironment and Is a Candidate Biomarker for Immunotherapy Response in Malignant Pleural Mesothelioma.
JTO Clin Res Rep
; 5(5): 100672, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38715965
14.
Randomized Controlled Trial of Thresholds for Drain Removal After Anatomic Lung Resection.
Ann Thorac Surg
; 2023 Sep 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37734641
15.
A multiplex inhalation platform to model in situ like aerosol delivery in a breathing lung-on-chip.
Front Pharmacol
; 14: 1114739, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36959848
16.
MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma.
Cell Death Discov
; 9(1): 55, 2023 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36765038
17.
Accuracy of diagnostic tests in cardiac injury after blunt chest trauma: a systematic review and meta-analysis.
World J Emerg Surg
; 18(1): 36, 2023 05 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37245048
18.
Non-genetic adaptive resistance to KRASG12C inhibition: EMT is not the only culprit.
Front Oncol
; 12: 1004669, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36483040
19.
Organoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?
Cancers (Basel)
; 14(15)2022 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35954422
20.
A Breakthrough Brought about by Targeting KRASG12C: Nonconformity Is Punished.
Cancers (Basel)
; 14(2)2022 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35053550